IDRX-42: Trial Design & Emerging Data from StrateGIST 1
Dr. Suzanne George of the Dana-Farber Cancer Institute will review emerging data from the first-in-human StrateGIST 1 trial of IDRX-42 in patients with advanced GIST.
Dr. Suzanne George of the Dana-Farber Cancer Institute will review emerging data from the first-in-human StrateGIST 1 trial of IDRX-42 in patients with advanced GIST.
GDOL Miami is being held virtually with the GIST experts at Sylvester Comprehensive Cancer Center.
Michelle Harris and Calvin Chao of Tempus will discuss the importance of biomarker testing in GIST, the process of biomarker testing, how to get testing done for free through The LRG, and more.
GDOL North Carolina is being held virtually Nov 6th, 3-5 pm ET at Chapel Hill, North Carolina.
Dr. Alcindor will discuss scientific updates relevant to GIST patients that were exhibited at the Connective Tissue Oncology Society (CTOS) conference.
Dr. Candace Haddox will present an overview of the Phase II SARC044 Clinical Trial.
Alianza GIST and FundaciΓ³n GIST MΓ©xico invite you to their upcoming Spanish-language webinar in honor of Rare Disease Day, featuring expert insights and patient perspectives.
The Summit will be held on Saturday, March 1, 2025, from 8:00 am until 6:00 pm and is co-hosted by MD Anderson Cancer Center, GIST Support International and The Life Raft Group.
GIST Advocate MarΓa Camila Gomez will discuss nutrition after GIST surgery, blending personal experience with nutrition studies.
La defensora de GIST, MarΓa Camila Gomez, hablarΓ‘ sobre la nutriciΓ³n despuΓ©s de la cirugΓa de GIST, combinando su experiencia personal con estudios de nutriciΓ³n.
Dr. Smith will share ways to live your best life using a holistic, person-centered approach.
La Sra. Tigre-Nerimora compartirΓ‘ formas de vivir al mΓ‘ximo con un enfoque holΓstico y centrado en las personas